HOME >> BIOLOGY >> NEWS
Leibniz Prize winners 2003

obtain twice the amount of photon energy at the intersection point of two coherent beams. This enables long-wave light to be used to achieve fluorescence effects which can otherwise only be produced with far greater energy, in other words shorter-wave light. This method offers advantages which can be exploited most importantly in the investigation of biological structures. It wasn't long before Winfried Denk was applying the advantages of the method he had developed to throw light on certain mysteries in the field of biology. Before long his area of interest was concentrated on the integration powers of nerve cells. Meanwhile, Winfried Denk has miniaturised his method to such an extent that it could soon become a realistic possibility to use it with free-moving animals. Entirely new approaches are emerging here for brain research.

Winfried Denk is currently a scientific member and Director of the Biomedical Optics Department of the Max Planck Institute for Medical Research in Heidelberg. He studied physics at the Ludwig-Maximilian University of Munich and the Swiss Federal Institute of Technology (ETH) in Zurich. He continued his studies at Cornell University in Ithaca, and then in 1989 he gained his doctorate in Professor W.W. Webb's laboratory. After a period of postdoctoral research in the IBM research laboratory in Rueshlikon he returned to the USA to a post at Bell Laboratories in Murray Hill, where he remained until he was offered a professorship at the Max Planck Society.

Prof. Dr. Hélène Esnault (49), algebraic geometry, Essen University, jointly with Prof. Dr. Eckart Viehweg (53), algebraic geometry, Essen University (1.55 million euros)

Hélène Esnault and Eckart Viehweg are the first married couple to be awarded the Leibniz Prize for scientific research carried out together. They have been working together for more than 20 years, and have produced around 25 substantial publications tog
'"/>

Contact: Ursula Rogmans-Beucher
ursula.rogmans-beucher@dfg.de
49-228-885-2726
Deutsche Forschungsgemeinschaft
3-Apr-2003


Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology news :

1. Leibniz Prizewinners 2004
2. Prizes awarded in the 2002 Gottfried Wilhelm Leibniz Programme
3. Leibniz Prize Winners 1999 - Most Highly Endowed German Promotional Prize For Ten Scientists
4. Half-million dollar landmark achieved for the Methuselah Mouse Prize
5. Winner of 2004 EMBO Science Writing Prize announced
6. Fox Chase Cancer Centers Alfred Knudson Jr. named 2004 Kyoto Prize winner
7. Stuart Lipton honored with Jung Prize for Medicine
8. 2004 Max Planck Research Prize for Martin Vingron and Eugene W. Myers
9. Scripps research scientist wins 2004 Koch Prize
10. Ohio State wetlands professor wins prestigious Water Prize
11. Tony Hunter and Raymond N. DuBois awarded Landon-AACR Prizes for Cancer Research

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Leibniz Prize winners

(Date:4/17/2014)... trials to treat tuberculosis could be the basis for ... bacteria, fungal infections and parasites, yet evade resistance, according ... collaborators. , Led by U. of I. chemistry professor ... drug SQ109 attacks the tuberculosis bacterium, how the drug ... to malaria and how targeting multiple pathways reduces ...
(Date:4/17/2014)... word for chili peppers. Information about archaeological remains of ... of the appearance of words for chili peppers in ... domesticated and highlight the value of multi-proxy data analysis. ... of nine papers presented in a special feature issue ... Sciences on plant and animal domestication edited by ...
(Date:4/17/2014)... West Orange, NJ. April 16, 2014. Kessler Foundation ... for $1.8 million from the Department of Defense ... PhD, is principal investigator for the randomized, double-blinded, ... to improve bone and muscle strength after spinal ... Human Performance & Engineering Research at Kessler Foundation. ...
Breaking Biology News(10 mins):Multitarget TB drug could treat other diseases, evade resistance 2Chickens to chili peppers 2Chickens to chili peppers 3Kessler Foundation awarded Department of Defense grant for spinal cord injury research 2
(Date:1/15/2014)... , Jan. 15, 2014 TaiGen Biotechnology Company, ... exclusive agreement with R-Pharm, a leading Russian pharmaceutical company, ... the Russian Federation , ... Independent States (CIS). Nemonoxacin is a novel antibiotic for the ...
(Date:1/14/2014)... 2014 Histogen, Inc., a regenerative medicine ... grown under simulated embryonic conditions, today announced that they ... Medical, Inc. for physician-dispensed aesthetic products containing Histogen’s proprietary ... agreement is an amendment to the existing license between ...
(Date:1/14/2014)... York, NY (PRWEB) January 14, 2014 ... of Alliqua, Inc. (OTCQB: ALQA). Alliqua is an emerging ... to serve the wound care market. , Free report ... was restructured with a seasoned management team and Board, ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 iLab Solutions, the ... as the new Director of Product Strategy. In this role, ... as iLab sub-teams to guide in the development of iLab ... provides the maximum possible benefit to the scientific community by ...
Breaking Biology Technology:TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2
Cached News: